EXCLUSIVE: Quantum BioPharma Contracts With Thermo Fisher Scientific Clinical Research Business To Support Phase 2 Trial For Neuroprotective Therapy In Multiple Sclerosis; Financial Terms Not Disclosed

Loading news article.

EXCLUSIVE: Quantum BioPharma Contracts With Thermo Fisher Scientific Clinical Research Business To Support Phase 2 Trial For Neuroprotective Therapy In Multiple Sclerosis; Financial Terms Not Disclosed | WAPE

EXCLUSIVE: Quantum BioPharma Contracts With Thermo Fisher Scientific Clinical Research Business To Support Phase 2 Trial For Neuroprotective Therapy In Multiple Sclerosis; Financial Terms Not Disclosed

Article summary

Related companies

Comments —